Vanta Bioscience Ltd
VANTABIOVanta Bioscience Ltd
VANTABIO
Price Chart
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| — | 2.10 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 50.09 | 6.40 | 0.53% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
The company is a preclinical contract research company. It provides preclinical safety assessment services, assessment services for evaluating the safety of the active pharmaceutical ingredients (API), etc.
Peers
Compare with peersDivi's Laboratories Ltd
Syngene International Ltd
Aarti Pharmalabs Ltd
Dishman Carbogen Amcis Ltd
Vimta Labs Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 4.04 | 12.65 | 14.25 | 10.07 | 10.11 | 6.97 | 9.83 | — | ||||||||
Raw Materials | 2.96 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||
| Power & Fuel Cost | 0.98 | 1.04 | 0.54 | 0.55 | 0.75 | 1.01 | ||||||||||
| Employee Cost | 2.90 | 3.93 | 2.51 | 2.67 | 3.46 | 3.79 | ||||||||||
| Selling & Administrative Expenses | 3.23 | 3.30 | 1.94 | 2.00 | 3.08 | 2.39 | ||||||||||
| Operating & Other expenses | 2.04 | 1.50 | 1.10 | 1.00 | 1.38 | 1.22 | ||||||||||
EBITDA | 1.08 | 3.50 | 4.48 | 3.98 | 3.89 | -1.70 | 1.42 | — | ||||||||
| Depreciation/Amortization | 0.57 | 0.71 | 1.19 | 1.25 | 1.32 | 2.67 | 4.50 | — | ||||||||
| PBIT | 0.51 | 2.79 | 3.29 | 2.73 | 2.57 | -4.37 | -3.08 | — | ||||||||
| Interest & Other Items | 0.20 | 1.69 | 1.95 | 2.14 | 2.35 | 5.89 | 5.75 | — | ||||||||
| PBT | 0.31 | 1.10 | 1.34 | 0.59 | 0.22 | -10.26 | -8.83 | — | ||||||||
| Taxes & Other Items | 0.29 | 0.40 | 0.34 | 0.14 | 0.14 | -3.78 | -6.51 | — | ||||||||
| Net Income | 0.02 | 0.70 | 1.00 | 0.45 | 0.08 | -6.48 | -2.32 | — | ||||||||
| EPS | 0.05 | 1.11 | 1.58 | 0.71 | 0.13 | -10.27 | -3.68 | — | ||||||||
| DPS | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CareLabs & Life Sciences Services
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Vanta Bioscience Ltd | -11.72 | 2.10 | — |
| Divi's Laboratories Ltd | 99.52 | 11.73 | 0.50% |
| Syngene International Ltd | 68.38 | 8.19 | 0.14% |
| Aarti Pharmalabs Ltd | 27.30 | 3.37 | 0.46% |
Price Comparison
Compare VANTABIO with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
No institutional holdings trend are available
Shareholding Pattern
Mar 2023
Sep 2023
Mar 2024
Sep 2024
Shareholding History
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
VANTABIO has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeVanta Bioscience will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
Vanta Bioscience has postponed the meeting of the Board of Directors which was scheduled to be held on 17 July 2024. The meeting will now be held on 19 July 2024.Powered by Capital Market - Live
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of -4.92%, vs industry avg of 4.51%
Decreasing Market Share
Over the last 5 years, market share decreased from 0.1% to 0.06%